£112.39

Humana Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)

Price data last checked 129 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£112 today · usual range £0–£0 · best ever £56

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 602 days • 602 data points (No recent data available)

Historical
Generating forecast...
£129.99 £49.03 £66.69 £84.36 £102.02 £119.69 £137.35 09 June 2024 06 November 2024 05 April 2025 02 September 2025 31 January 2026

Price Distribution

Price distribution over 602 days • 8 price levels

Days at Price
Current Price
30 days 22 days 82 days 165 days 137 days 66 days 46 days · current 54 days 0 41 83 124 165 £56 £103 £104 £105 £107 £108 £112 £130 Days at Price

Price Analysis

Most common price: £105 (165 days, 27.4%)

Price range: £56 - £130

Price levels: 8 different prices over 602 days

Description

This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects of genetic, epigenetic, developmental, and environmental determinants on T cell function. Other topics covered include the ex vivo expansion of T or other immune cells and their genetic modification or reprogramming to increase their ability to survive and expand when adoptively transferred back to the patients. Specific attention is devoted to the genetic manipulation of T cells through the introduction of re-directed T cell receptors, chimeric antibody receptors, and other genetic manipulation aimed at improving their effectiveness as anti-cancer agents. Furthermore, the revolutionary role of checkpoint inhibitors and their potential in combination with other immunotherapeutic approaches or with standard chemo and radiation therapy are extensively discussed.

Product Specifications

Brand
Humana
Format
Paperback
Domain
Amazon UK
Release Date
14 March 2019
Listed Since
20 December 2018

Barcode

No barcode data available

Similar Products You Might Like

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
98% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 12 Apr 2026
Critical Developments in Cancer Immunotherapy
98% match

Critical Developments in Cancer Immunotherapy

£421.00 12 Apr 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
98% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£73.91 07 Mar 2026
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
98% match

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

£110.06 13 Jan 2026
Springer - Immunotherapy of Cancer: An Innovative Treatment
98% match

Springer - Immunotherapy of Cancer: An Innovative Treatment

Springer

£110.34 18 Apr 2026
Immunotherapy of Cancer (Cancer Drug Discovery and Development)
98% match

Immunotherapy of Cancer (Cancer Drug Discovery and Development)

Humana

£67.77 10 Mar 2026
Immunotherapy of Cancer (Cancer Drug Discovery and Development)
98% match

Immunotherapy of Cancer (Cancer Drug Discovery and Development)

Humana

£147.58 12 Jan 2026
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
98% match

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

Springer

£156.60 11 Jan 2026
Progress in Cancer Immunotherapy: 909 (Advances in Experimental Medicine and Biology, 909)
98% match

Progress in Cancer Immunotherapy: 909 (Advances in Experimental Medicine and Biology, 909)

Springer

£103.81 07 Jan 2026
Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
97% match

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors

Springer

£156.60 12 Jan 2026
Immunotherapy in Translational Cancer Research (Translational Oncology)
97% match

Immunotherapy in Translational Cancer Research (Translational Oncology)

Wiley

£135.04 24 Jan 2026
Immune-based Cancer Treatment: The T Iymphocyte Response
97% match

Immune-based Cancer Treatment: The T Iymphocyte Response

CRC Press

£67.80 26 Feb 2026
Cancer Immunotherapy (Advances in Immunology): Volume 90
97% match

Cancer Immunotherapy (Advances in Immunology): Volume 90

Academic Press

£61.72 17 Mar 2026
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
97% match

Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)

CRC Press

£188.36 08 Mar 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
97% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£105.81 08 Feb 2026
Immunotherapy of Cancer (Volume 128) (Advances in Cancer Research, Volume 128)
97% match

Immunotherapy of Cancer (Volume 128) (Advances in Cancer Research, Volume 128)

Academic Press

£111.95 09 Mar 2026
Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)
97% match

Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)

Springer

£144.12 10 Mar 2026
Cancer Immunology: A Translational Medicine Context
97% match

Cancer Immunology: A Translational Medicine Context

Springer

£116.13 27 Feb 2026
Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)
97% match

Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)

CRC Press

£79.41 08 Mar 2026
Chimeric Antigen Receptor T-Cell Therapies for Cancer: A Practical Guide
97% match

Chimeric Antigen Receptor T-Cell Therapies for Cancer: A Practical Guide

Elsevier

£53.59 18 Apr 2026
Cell Reprogramming for Immunotherapy: Methods and Protocols: 2097 (Methods in Molecular Biology, 2097)
97% match

Cell Reprogramming for Immunotherapy: Methods and Protocols: 2097 (Methods in Molecular Biology, 2097)

Humana

£110.41 18 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
97% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
97% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
CRC Press - Tumor Immunology and Cancer Therapy: 61 Book
97% match

CRC Press - Tumor Immunology and Cancer Therapy: 61 Book

CRC Press

£76.59 10 Mar 2026